PMS2 and colorectal carcinoma: The purpose of this study was to describe the metachronous CRC incidence by including all individuals with variants in MLH1, MSH2, MSH6, and PMS2 and cross-referencing with CRC diagnoses and colon polyp diagnoses from the Icelandic Cancer Registry from 1955 to 2017.